Reply: Subacute thyroiditis after anti-SARS-CoV-2 (Ad5-nCoV) vaccine.
作者信息
Flores-Rebollar Armando
机构信息
Departamento de Medicina Interna, Instituto Nacional de Ciencias Médicas y Nutrición «Salvador Zubirán», Mexico City, Mexico.
出版信息
Enferm Infecc Microbiol Clin (Engl Ed). 2022 Jun-Jul;40(6):345-346. doi: 10.1016/j.eimce.2022.03.005. Epub 2022 Apr 26.
Abstract
摘要
相似文献
1
Reply: Subacute thyroiditis after anti-SARS-CoV-2 (Ad5-nCoV) vaccine.回复：抗SARS-CoV-2（Ad5-nCoV）疫苗接种后亚急性甲状腺炎
Enferm Infecc Microbiol Clin (Engl Ed). 2022 Jun-Jul;40(6):345-346. doi: 10.1016/j.eimce.2022.03.005. Epub 2022 Apr 26.
2
Subacute thyroiditis after anti-SARS-CoV-2 (Ad5-nCoV) vaccine.
Enferm Infecc Microbiol Clin (Engl Ed). 2022 Oct;40(8):459-460. doi: 10.1016/j.eimce.2022.05.008. Epub 2022 May 19.
3
Three Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccine: Postvaccination ASIA Syndrome.三例接种 SARS-CoV-2 疫苗后亚急性甲状腺炎：疫苗接种后 ASIA 综合征。
J Clin Endocrinol Metab. 2021 Aug 18;106(9):2600-2605. doi: 10.1210/clinem/dgab373.
4
Subacute thyroiditis after inactive SARS-CoV-2 vaccine.接种灭活 SARS-CoV-2 疫苗后发生亚急性甲状腺炎。
BMJ Case Rep. 2021 Oct 1;14(10):e244711. doi: 10.1136/bcr-2021-244711.
5
Subacute Thyroiditis Following SARS-CoV-2 Vaccines: Six Cases Report and Review of the Literature.接种 SARS-CoV-2 疫苗后的亚急性甲状腺炎：六例报告及文献复习。
Horm Metab Res. 2022 Aug;54(8):556-561. doi: 10.1055/a-1804-9561. Epub 2022 Mar 22.
6
Subacute thyroiditis after SARS-CoV2 vaccine: possible relapse after boosting.接种新型冠状病毒2型疫苗后发生亚急性甲状腺炎：加强免疫后可能复发。
J Endocrinol Invest. 2022 Oct;45(10):2019-2020. doi: 10.1007/s40618-022-01856-w. Epub 2022 Jul 5.
7
Response to Letter to the Editor From Raven: Three Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccine.对《乌鸦》杂志编辑来信的回复：3例新型冠状病毒疫苗接种后亚急性甲状腺炎病例
J Clin Endocrinol Metab. 2022 Mar 24;107(4):e1773-e1774. doi: 10.1210/clinem/dgab823.
8
Letter to the Editor From Raven et al: "Three Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccine".来自拉文等人致编辑的信：“三例接种新型冠状病毒疫苗后发生的亚急性甲状腺炎”
J Clin Endocrinol Metab. 2022 Mar 24;107(4):e1767-e1768. doi: 10.1210/clinem/dgab822.
9
Letter to the Editor From Kleebayoon and Wiuwanikit: "Subacute THYROiditis Related to SARS-CoV-2 VAccine and Covid-19 (THYROVAC Study): A Multicenter Nationwide Study".来自Kleebayoon和Wiuwanikit给编辑的信：“与SARS-CoV-2疫苗和新冠病毒相关的亚急性甲状腺炎（THYROVAC研究）：一项全国多中心研究”
J Clin Endocrinol Metab. 2023 Dec 21;109(1):e432. doi: 10.1210/clinem/dgad428.
10
Response to Letter to the Editor From Kleebayoon and Wiuwanikit: "Subacute THYROiditis Related to SARS-CoV-2 Vaccine and COVID-19 (THYROVAC Study): A Multicenter Nationwide Study".对Kleebayoon和Wiuwanikit致编辑信的回复：“与SARS-CoV-2疫苗和COVID-19相关的亚急性甲状腺炎（THYROVAC研究）：一项全国多中心研究”
J Clin Endocrinol Metab. 2023 Dec 21;109(1):e436. doi: 10.1210/clinem/dgad462.
本文引用的文献
1
Subacute thyroiditis after COVID-19 vaccination.新冠病毒疫苗接种后亚急性甲状腺炎
Enferm Infecc Microbiol Clin. 2022 Jun-Jul;40(6):345. doi: 10.1016/j.eimc.2021.12.010. Epub 2022 Jan 24.
2
[Subacute thyroiditis after anti-SARS-CoV-2 (Ad5-nCoV) vaccine].[抗SARS-CoV-2（腺病毒5型载体新冠病毒疫苗）接种后亚急性甲状腺炎]
Enferm Infecc Microbiol Clin. 2022 Oct;40(8):459-460. doi: 10.1016/j.eimc.2021.10.015. Epub 2021 Nov 18.
3
The Prevalence of Euthyroid Hypertriiodothyroninemia in Newly Diagnosed Multiple Myeloma and its Clinical Characteristics.初诊多发性骨髓瘤患者中甲状腺功能正常的高甲状腺素血症的患病率及其临床特征
Endocr Pract. 2021 Mar;27(3):236-240. doi: 10.1016/j.eprac.2020.09.004. Epub 2020 Dec 13.
4
Interferences With Thyroid Function Immunoassays: Clinical Implications and Detection Algorithm.甲状腺功能免疫测定的干扰：临床意义和检测算法。
Endocr Rev. 2018 Oct 1;39(5):830-850. doi: 10.1210/er.2018-00119.
5
Interference in thyroid-stimulating hormone determination.干扰促甲状腺激素测定。
Eur J Clin Invest. 2010 Aug;40(8):756-8. doi: 10.1111/j.1365-2362.2010.02315.x. Epub 2010 Jun 7.
6
Circulating thyroid hormones in a patient with hyperviscosity syndrome.高黏滞综合征患者的循环甲状腺激素
Clin Chim Acta. 1979 Apr 16;93(2):263-8. doi: 10.1016/0009-8981(79)90098-6.
Zotero 插件